IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
-0.53%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$241M
AUM Growth
-$87.5M
(-27%)
Cap. Flow
-$38.6M
Cap. Flow
% of AUM
-16.02%
Top 10 Holdings %
Top 10 Hldgs %
47.34%
Holding
189
New
16
Increased
13
Reduced
42
Closed
72
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$13.1M |
| 2 |
Altimmune
ALT
|
$10.5M |
| 3 |
United Therapeutics
UTHR
|
$9.43M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$8.75M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.33M |
Top Sells
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$21M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$9.33M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 5 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$6.98M |
Sector Composition
| 1 | Healthcare | 98.31% |
| 2 | Technology | 0.25% |
| 3 | Consumer Staples | 0.07% |
| 4 | Financials | 0% |
